CTF is pleased to announce its support of the REiNS (Response Evaluation in Neurofibromatosis and Schwannomatosis) Initiative.
REiNS is an international effort to develop new standardized response criteria for determining treatment response in patients with NF1, NF2, and schwannomatosis. Response criteria will continue to be modified as we gain experience in clinical trials for NF. We hope these criteria will be incorporated into future clinical trials and will improve our ability to determine and compare treatment efficacy.
For more information please click here.